5 Results for "

Toceranib

" in MedChemExpress (MCE) Product Catalog:
Products (5)

5 Results for "Toceranib" in MCE Product Catalog:

Cat. No.: HY-10330
CAS No.: 356068-94-5
Purity:  97.32%
Synonyms: SU11654; PHA 291639E
Target:  

PDGFR VEGFR c-Kit

Research Areas:  

Cancer

Toceranib phosphate (SU11654 phosphate) is an orally active receptor tyrosine kinase (RTK) inhibitor, and it potently inhibits PDGFR, VEGFR, and Kit with Kis of 5 and 6 nM for PDGFRβ and Flk-1/KDR, respectively. Toceranib phosphate (SU11654 phosphate) has antitumor and antiangiogenic activity, and used in the treatment of canine mast cell tumors .
loading...
    loading...
Cat. No.: HY-10330A
CAS No.: 874819-74-6
Purity:  98.54%
Synonyms: SU11654 phosphate; PHA 291639E phosphate
Target:  

PDGFR VEGFR c-Kit

Research Areas:  

Cancer

Toceranib phosphate (SU11654 phosphate) is an orally active receptor tyrosine kinase (RTK) inhibitor, and it potently inhibits PDGFR, VEGFR, and Kit with Kis of 5 and 6 nM for PDGFRβ and Flk-1/KDR, respectively. Toceranib phosphate (SU11654 phosphate) has antitumor and antiangiogenic activity, and used in the treatment of canine mast cell tumors .
loading...
    loading...
Cat. No.: HY-10330S
CAS No.: 1795134-78-9
Purity:  99.08%
Toceranib-d8 is the deuterium labeled Toceranib. Toceranib (SU11654) is an orally active receptor tyrosine kinase (RTK) inhibitor, and it potently inhibits PDGFR, VEGFR, and Kit with Kis of 5 and 6 nM for PDGFRβ and Flk-1/KDR, respectively. Toceranib (SU11654) has antitumor and antiangiogenic activity, and used in the treatment of canine mast cell tumors .
loading...
    loading...
Cat. No.: HY-10330AR
CAS No.: 874819-74-6
Synonyms: SU11654 phosphate (Standard); PHA 291639E phosphate (Standard)
Research Areas:  

Cancer

Toceranib phosphate (Standard) is the analytical standard of Toceranib phosphate (HY-10330A). This product is intended for research and analytical applications. Toceranib phosphate (SU11654 phosphate) is an orally active receptor tyrosine kinase (RTK) inhibitor, and it potently inhibits PDGFR, VEGFR, and Kit with Kis of 5 and 6 nM for PDGFRβ and Flk-1/KDR, respectively. Toceranib phosphate (SU11654 phosphate) has antitumor and antiangiogenic activity, and used in the treatment of canine mast cell tumors .
loading...
    loading...
Cat. No.: HY-10330R
CAS No.: 356068-94-5
Synonyms: SU11654 (Standard); PHA 291639E (Standard)
Research Areas:  

Cancer

Toceranib (Standard) is the analytical standard of Toceranib (HY-10330). This product is intended for research and analytical applications. Toceranib phosphate (SU11654 phosphate) is an orally active receptor tyrosine kinase (RTK) inhibitor, and it potently inhibits PDGFR, VEGFR, and Kit with Kis of 5 and 6 nM for PDGFRβ and Flk-1/KDR, respectively. Toceranib phosphate (SU11654 phosphate) has antitumor and antiangiogenic activity, and used in the treatment of canine mast cell tumors .
loading...
    loading...